Shalin Shah is the founder & CEO of Marius Pharmaceuticals, the company that partnered with $HIMS to launch oral testosterone (KYZATREX). We discuss how the partnership came about, the benefits of teaming up with $HIMS, and the future of TRT.

(00:41) Origin of the partnership

(02:55) Benefits of partnering with $HIMS

(04:14) Deal shape and exclusivity

(06:51) How KYZATREX will sit alongside compounded meds on the $HIMS platform

(09:22) Will KYZATREX be personalized?

(16:07) TRT as a schedule 3 substance

(21:39) Gearing up for 2026 launch of KYZATREX

(22:40) Future of TRT market

(27:29) Peptides

(29:44) Testosterone for females

Get full access to Hims House at himshouse.substack.com/subscribe